Literature DB >> 19474247

Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates.

Masayuki Saijo1, Yasushi Ami, Yuriko Suzaki, Noriyo Nagata, Naoko Iwata, Hideki Hasegawa, Itoe Iizuka, Tomoyuki Shiota, Kouji Sakai, Momoko Ogata, Shuetsu Fukushi, Tetsuya Mizutani, Tetsutaro Sata, Takeshi Kurata, Ichiro Kurane, Shigeru Morikawa.   

Abstract

Monkeypox virus is divided into Congo Basin and West African strains. The virulence and pathophysiology of two strains, Zr-599 (a Congo Basin monkeypox virus) and Liberia (a West African monkeypox virus), were evaluated in non-human primates. Four monkeys were infected by the subcutaneous (SC) and two by the intranasal (IN) inoculation routes for Zr-599 and Liberia at a dose of 10(6) p.f.u. One monkey in the Liberia/SC group was demonstrated to be co-infected with Gram-positive cocci and was excluded from analyses. Infections in three of the four Zr-599/SC monkeys and in one of the three Liberia/SC monkeys were fatal. Virus genome levels in blood in the Zr-599/SC monkeys were approximately 10 times higher than those in the Liberia/SC monkeys. Zr-599 affected respiratory, genito-urinary and gastrointestinal tract organs more severely than Liberia. Zr-599 was more virulent than Liberia and one of the factors might be the difference in organ tropism.

Entities:  

Mesh:

Year:  2009        PMID: 19474247     DOI: 10.1099/vir.0.010207-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection.

Authors:  Ryan D Estep; Ilhem Messaoudi; Megan A O'Connor; Helen Li; Jerald Sprague; Alexander Barron; Flora Engelmann; Bonnie Yen; Michael F Powers; John M Jones; Bridget A Robinson; Beata U Orzechowska; Minsha Manoharan; Alfred Legasse; Shannon Planer; Jennifer Wilk; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Evaluation of monkeypox disease progression by molecular imaging.

Authors:  Julie Dyall; Reed F Johnson; Dar-Yeong Chen; Louis Huzella; Dan R Ragland; Daniel J Mollura; Russell Byrum; Richard C Reba; Gerald Jennings; Peter B Jahrling; Joseph E Blaney; Jason Paragas
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

3.  A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012.

Authors:  Scott Parker; R Mark Buller
Journal:  Future Virol       Date:  2013-02-01       Impact factor: 1.831

4.  Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.

Authors:  Noriyo Nagata; Masayuki Saijo; Michiyo Kataoka; Yasushi Ami; Yuriko Suzaki; Yuko Sato; Naoko Iwata-Yoshikawa; Momoko Ogata; Ichiro Kurane; Shigeru Morikawa; Tetsutaro Sata; Hideki Hasegawa
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity.

Authors:  Livia V Patrono; Kamilla Pléh; Liran Samuni; Markus Ulrich; Caroline Röthemeier; Andreas Sachse; Silvia Muschter; Andreas Nitsche; Emmanuel Couacy-Hymann; Christophe Boesch; Roman M Wittig; Sébastien Calvignac-Spencer; Fabian H Leendertz
Journal:  Nat Microbiol       Date:  2020-04-27       Impact factor: 17.745

Review 6.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

7.  A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Authors:  George W Buchman; Matthew E Cohen; Yuhong Xiao; Nicola Richardson-Harman; Peter Silvera; Louis J DeTolla; Heather L Davis; Roselyn J Eisenberg; Gary H Cohen; Stuart N Isaacs
Journal:  Vaccine       Date:  2010-07-24       Impact factor: 3.641

8.  Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route.

Authors:  Reed F Johnson; Julie Dyall; Dan R Ragland; Louis Huzella; Russell Byrum; Catherine Jett; Marisa St Claire; Alvin L Smith; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

9.  Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus.

Authors:  J A Tree; G Hall; G Pearson; E Rayner; V A Graham; K Steeds; K R Bewley; G J Hatch; M Dennis; I Taylor; A D Roberts; S G P Funnell; J Vipond
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

10.  Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.

Authors:  Adam Macneil; Mary G Reynolds; Zach Braden; Darin S Carroll; Vanda Bostik; Kevin Karem; Scott K Smith; Whitni Davidson; Yu Li; Amba Moundeli; Jean-Vivien Mombouli; Aisha O Jumaan; D Scott Schmid; Russell L Regnery; Inger K Damon
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.